| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 125,138 | 102,745 | ||
| Short-term marketable securities | 296,545 | 239,481 | ||
| Trade receivables, net of allowances | 69,629 | 64,567 | ||
| Inventory | 12,349 | 12,276 | ||
| Prepaid expenses and other current assets | 37,469 | 24,043 | ||
| Total current assets | 541,130 | 443,112 | ||
| Strategic inventory | 12,002 | 7,991 | ||
| Operating lease right-of-use asset | 4,776 | 4,964 | ||
| Property and equipment, net | 2,094 | 2,348 | ||
| Long-term marketable securities | 102,557 | 172,775 | ||
| Other assets | 8,049 | 8,303 | ||
| Deferred tax assets, net | 152,999 | 162,229 | ||
| Total assets | 823,607 | 801,722 | ||
| Accounts payable | 34,446 | 23,525 | ||
| Accrued research and development expenses | 28,322 | 29,049 | ||
| Accrued and other liabilities | 108,447 | 91,073 | ||
| Short-term operating lease liability | 1,050 | 1,017 | ||
| Total current liabilities | 172,265 | 144,664 | ||
| Long-term operating lease liability | 5,308 | 5,588 | ||
| Long-term accrued income taxes payable | 14,132 | 15,677 | ||
| Total liabilities | 191,705 | 165,929 | ||
| Preferred stock | 0 | 0 | ||
| Common stock | 139 | 138 | ||
| Treasury stock | 923,290 | 866,931 | ||
| Additional paid-in capital | 933,613 | 900,864 | ||
| Accumulated other comprehensive income (loss) | 2,341 | 2,291 | ||
| Retained earnings | 619,099 | 599,431 | ||
| Total stockholders equity | 631,902 | 635,793 | ||
| Total liabilities and stockholders equity | 823,607 | 801,722 | ||
CORCEPT THERAPEUTICS INC (CORT)
CORCEPT THERAPEUTICS INC (CORT)